Abstract
TRC102 inhibits base excision repair by binding abasic sites and preventing AP endonuclease processing; it potentiates the activity of alkylating agents, including temozolomide, in murine models. In published xenograft studies, TRC102 enhanced the antitumor effect of temozolomide regardless of cell line genetic characteristics, e.g., O6-methylguanine DNA methyltransferase (MGMT), mismatch repair (MMR), or p53 status. We conducted a phase 1 trial of TRC102 with temozolomide given orally on days 1-5 of 28-day cycles in adult patients with refractory solid tumors that had progressed on standard therapy. Tumor induction of nuclear biomarkers of DNA damage response (DDR) γH2AX, pNBs1, and Rad51 was assessed in the context of MGMT and MMR protein expression for expansion cohort patients. Fifty-two patients were enrolled (37 escalation, 15 expansion) with 51 evaluable for response. The recommended phase 2 dose was 125 mg TRC102, 150 mg/m2 temozolomide QDx5. Common adverse events (grade 3/4) included anemia (19%), lymphopenia (12%), and neutropenia (10%). Four patients achieved partial responses (1 non-small cell lung cancer, 2 granulosa cell ovarian cancer, and 1 colon cancer) and 13 patients had a best response of stable disease. Ret...Continue Reading
References
Jan 1, 1997·Cancer Treatment Reviews·E S NewlandsC Brock
Nov 27, 1999·British Journal of Cancer·M BradaD Cutler
Feb 24, 2001·Journal of Pharmaceutical and Biomedical Analysis·H KimA A Nomeir
May 24, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R DziadziuszkoUNKNOWN EORTC Lung Cancer Group
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Jan 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lili Liu, Stanton L Gerson
Mar 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ling YanLili Liu
Apr 11, 2008·Brain Pathology·Matthias PreusserMonika Hegi
May 14, 2008·Anti-cancer Agents in Medicinal Chemistry·Ida CasorelliMargherita Bignami
Jan 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matthew H KulkeMark S Redston
Jan 21, 2009·Cellular and Molecular Life Sciences : CMLS·A B RobertsonI Leiros
Mar 10, 2009·The Lancet Oncology·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
May 7, 2010·CA: a Cancer Journal for Clinicians·Erwin G Van MeirJeffrey J Olson
Jun 30, 2012·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Shuming YangYan Xu
Oct 12, 2012·Investigational New Drugs·Michael S GordonGlen J Weiss
Jan 19, 2013·Neuro-oncology·Shadi LalezariAlbert Lai
Mar 12, 2013·Nucleic Acids Research·Timothy J TricheKimberly D Siegmund
Jan 1, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F PietrantonioM Di Bartolomeo
Jun 21, 2014·Future Oncology·Mark R KelleyMelissa L Fishel
Jul 16, 2014·Trends in Genetics : TIG·Felix DietleinH Christian Reinhardt
Dec 18, 2015·Epigenomics·Sebastian MoranManel Esteller
Mar 24, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Apurva K SrivastavaRalph E Parchment
Dec 8, 2016·Nucleic Acids Research·Wanding ZhouHui Shen
Apr 21, 2017·British Journal of Cancer·M A CalegariC Barone
Nov 8, 2017·Oncotarget·Paolo F CaimiStanton L Gerson
Nov 19, 2017·Endocrine·Davide CampanaGuido Biasco
Apr 5, 2018·Cell Reports·Theo A KnijnenburgChen Wang
May 2, 2018·Scientific Reports·Arshad A PandithNiyaz A Naikoo
Aug 8, 2018·Nucleic Acids Research·Wanding ZhouHui Shen
Oct 5, 2018·Journal of Oncology Practice·Katherine V Ferry-GalowAlice P Chen
Feb 23, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Deborah F WilskerRobert J Kinders
Jun 13, 2019·Journal of Hospital Management and Health Policy·Katherine V Ferry-Galow, Alice P Chen
Jul 26, 2019·Cell Systems·Galen F GaoMichael S Noble
Jun 20, 2020·Investigational New Drugs·Jennifer R EadsAfshin Dowlati